Medscape Education, the leader in continuing medical education for healthcare professionals, is extending its commitment to ...

Johnson & Johnson’s (J&J) Lazcluze (lazertinib) has been approved by the Medicines and Healthcare products Regulatory Agency ...

AstraZeneca (AZ) has shared positive results from a late-stage trial of its Imfinzi (durvalumab)-based perioperative regimen ...

Takeda and Protagonist Therapeutics have shared positive top-line results from a phase 3 trial of rusfertide in the rare ...

Medicine is constantly evolving, but progress is only meaningful if it reaches everyone. Health outcomes are shaped not just ...

Eli Lilly’s Jaypirca (pirtobrutinib) has been recommended by the European Medicines Agency’s (EMA) human medicines committee ...

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the Medicines and Healthcare products ...

Patient journeys have long been a cornerstone in the pharmaceutical industry for understanding the way individuals navigate ...

Regeneron Pharmaceuticals has received a positive opinion from the European Medicines Agency’s human medicines committee for ...

The Healthcare Communications Association has recently revitalised its long-established efforts to evaluate impact (those of ...

Red hot preview coming to you today, as we’re soon to launch our new Media Vitals Global HCP report, offering insights around ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Galderma’s Nemluvio (nemolizumab) to treat both ...